SE8104661L - Stabil mikrokristallin form av cisplatin, forfarande for framstellning derav samt stabil, steril torrblandningsberedning derav - Google Patents

Stabil mikrokristallin form av cisplatin, forfarande for framstellning derav samt stabil, steril torrblandningsberedning derav

Info

Publication number
SE8104661L
SE8104661L SE8104661A SE8104661A SE8104661L SE 8104661 L SE8104661 L SE 8104661L SE 8104661 A SE8104661 A SE 8104661A SE 8104661 A SE8104661 A SE 8104661A SE 8104661 L SE8104661 L SE 8104661L
Authority
SE
Sweden
Prior art keywords
stable
cisplatin
microcristallin
preparing
procedure
Prior art date
Application number
SE8104661A
Other languages
Unknown language ( )
English (en)
Other versions
SE450830B (sv
Inventor
M A Kaplan
A P Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8104661L publication Critical patent/SE8104661L/sv
Publication of SE450830B publication Critical patent/SE450830B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G55/00—Compounds of ruthenium, rhodium, palladium, osmium, iridium, or platinum
    • C01G55/002—Compounds containing, besides ruthenium, rhodium, palladium, osmium, iridium, or platinum, two or more other elements, with the exception of oxygen or hydrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/74—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by peak-intensities or a ratio thereof only
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/51—Particles with a specific particle size distribution
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/60—Particles characterised by their size
    • C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/80—Compositional purity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
SE8104661A 1979-10-02 1981-08-03 Stabil mikrokristallin cis-platina(ii)-diamin-diklorid och forfarande for dess framstellning SE450830B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/081,301 US4302446A (en) 1979-10-02 1979-10-02 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
SE8104661L true SE8104661L (sv) 1983-02-04
SE450830B SE450830B (sv) 1987-08-03

Family

ID=22163311

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8104661A SE450830B (sv) 1979-10-02 1981-08-03 Stabil mikrokristallin cis-platina(ii)-diamin-diklorid och forfarande for dess framstellning
SE8300623A SE455469B (sv) 1979-10-02 1983-02-07 Farmaceutisk komposition innehallande stabil, mikrokristallin cis-platina (ii)-diammindiklorid

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8300623A SE455469B (sv) 1979-10-02 1983-02-07 Farmaceutisk komposition innehallande stabil, mikrokristallin cis-platina (ii)-diammindiklorid

Country Status (12)

Country Link
US (2) US4302446A (sv)
JP (1) JPS5832029A (sv)
AT (1) AT375326B (sv)
AU (1) AU551710B2 (sv)
BE (1) BE890192A (sv)
CA (1) CA1152289A (sv)
CH (1) CH647216A5 (sv)
DE (1) DE3133443A1 (sv)
FR (1) FR2511357B1 (sv)
GB (1) GB2103591B (sv)
NL (1) NL8103784A (sv)
SE (2) SE450830B (sv)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
DE3305248A1 (de) * 1983-02-16 1984-08-16 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von reinem cis-platin-(ii)-diammin-dichlorid
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
US4699978A (en) * 1985-01-18 1987-10-13 The Trustees Of Columbia University In The City Of New York Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents
US4686104A (en) * 1985-04-30 1987-08-11 Sloan-Kettering Institute For Cancer Research Methods of treating bone disorders
JPS61293655A (ja) * 1985-05-31 1986-12-24 Trinity Ind Corp 砂型鋳造品の砂落し装置
CS269719B1 (en) * 1986-12-29 1990-05-14 Kiss Frantisek Platinum cytostatic
JP2657393B2 (ja) * 1988-05-18 1997-09-24 日本化薬株式会社 化学塞栓療法剤
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
US4946689A (en) * 1988-11-23 1990-08-07 Bristol-Myers Company Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
US8728536B2 (en) * 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
US6251355B1 (en) 1996-12-25 2001-06-26 Nippon Kayaku Kabushiki Kaisha Fine cisplatin powder and process for the production thereof
US6074626A (en) * 1998-03-20 2000-06-13 Molecular Radiation Management, Inc. Radioactive cisplatin in the treatment of cancer
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
DE60125429T2 (de) * 2000-04-24 2007-09-27 Teva Pharmaceutical Industries Ltd. Zolpidem hemitartrat solvat
EP1600159A1 (en) 2000-04-24 2005-11-30 Teva Pharmaceutical Industries Ltd A method for synthesizing different Zolpidem hemitartrate derivatives
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
JP2005510471A (ja) * 2001-09-24 2005-04-21 トスク インコーポレーティッド 減少した毒性のシスプラチン製剤及びそれを使用する方法
DE602004028585D1 (de) * 2003-03-15 2010-09-23 Brin Tech Internat Ltd Verpackung für Arzneimittel
WO2004087126A1 (en) * 2003-03-31 2004-10-14 Pliva-Lachema A.S. Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof
CA2542499A1 (en) * 2003-10-16 2005-04-28 Teva Pharmaceutical Industries Ltd. Preparation of candesartan cilexetil
JP2007517803A (ja) * 2004-01-05 2007-07-05 テバ ファーマシューティカル インダストリーズ リミティド シルデナフィル塩基とクエン酸塩の製造方法
EP1713795A2 (en) * 2004-02-11 2006-10-25 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
US20080085882A1 (en) * 2006-08-18 2008-04-10 University Of North Texas Health Science Center At Fort Worth Compositions and Methods for Potentiation of Cancer Agents
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) * 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
WO2008097658A1 (en) * 2007-02-09 2008-08-14 Poniard Pharmaceuticals, Inc. Encapsulated picoplatin
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
EP2178893A4 (en) * 2007-07-16 2012-09-19 Poniard Pharmaceuticals Inc ORAL FORMULATIONS FOR PICOPLATIN
AU2009210654A1 (en) * 2008-02-08 2009-08-13 Poniard Pharmaceuticals, Inc. Use of picoplatin and bevacizumab to treat colorectal cancer
WO2009113989A1 (en) 2008-03-14 2009-09-17 Bionumerik Pharmaceuticals, Inc. Compositions and methods of use of compounds to increase cancer patient survival time
JP5694782B2 (ja) 2008-03-14 2015-04-01 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド 肺癌、腺癌及び他の病状のための治療方法及び組成物
US20100035853A1 (en) * 2008-08-07 2010-02-11 Hyogo College Of Medicine Method for preventing or treating cisplatin-induced nephrotoxicity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079121A (en) * 1974-12-13 1978-03-14 Mobil Oil Corporation Complexes of beta platinum chloride and ammonia
CA1119954A (en) * 1978-05-30 1982-03-16 Edmund S. Granatek Aqueous solution of cisplatin
US4273755A (en) * 1979-08-16 1981-06-16 Mpd Technology Corporation Preparation of platinum complexes

Also Published As

Publication number Publication date
US4302446A (en) 1981-11-24
FR2511357B1 (fr) 1986-09-05
AT375326B (de) 1984-07-25
JPH0313174B2 (sv) 1991-02-21
ATA374981A (de) 1983-12-15
CA1152289A (en) 1983-08-23
FR2511357A1 (fr) 1983-02-18
NL8103784A (nl) 1983-03-01
US4322391A (en) 1982-03-30
AU7390681A (en) 1983-02-10
AU551710B2 (en) 1986-05-08
GB2103591A (en) 1983-02-23
SE455469B (sv) 1988-07-18
CH647216A5 (de) 1985-01-15
SE8300623L (sv) 1983-02-07
DE3133443A1 (de) 1983-03-10
BE890192A (fr) 1982-03-02
SE450830B (sv) 1987-08-03
GB2103591B (en) 1985-03-06
SE8300623D0 (sv) 1983-02-07
JPS5832029A (ja) 1983-02-24

Similar Documents

Publication Publication Date Title
SE8104661L (sv) Stabil mikrokristallin form av cisplatin, forfarande for framstellning derav samt stabil, steril torrblandningsberedning derav
SE8402551D0 (sv) Cinnamoylmoranolin-derivat
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
NO163776C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazoquinoksaliner.
DE3267039D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
NO150638C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, basiske ethere
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
FI940696A (sv) Nya pyrazinderivat, deras framställning och användning
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
SE8204874L (sv) Farmaceutiska preparat, innefattande humant insulin och humant proinsulin
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3061907D1 (en) 6-imidazol-1-yl-3-hydrazino-pyridazines, process for preparing them and medicaments containing them
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE111731T1 (de) Pharmazeutische zubereitung zur rektalen verabreichung.
SE8008456L (sv) Komposition och framstellning derav
ES8106895A1 (es) Procedimiento para la obtencion de derivados aminopropanoli-cos del 5-(2-hidroxi-estiril)-isoxazol
JPS57167925A (en) Preparation of mixed vaccine for domestic fowl
FR2276033A1 (fr) Derives actifs d'acetoxime, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
JPS5699420A (en) Immune reactivator
ES466627A1 (es) Procedimiento para la obtencion de derivados amino del 4-hi-droxi-1,2-benzisotiazol

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8104661-7

Effective date: 19940310

Format of ref document f/p: F